Bracco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRACCO, and what generic alternatives to BRACCO drugs are available?
BRACCO has forty approved drugs.
There are three US patents protecting BRACCO drugs.
There are thirty-four patent family members on BRACCO drugs in twelve countries and seventy-three supplementary protection certificates in eight countries.
Drugs and US Patents for Bracco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | ORAGRAFIN CALCIUM | ipodate calcium | GRANULE;ORAL | 012968-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | ISOVUE-250 | iopamidol | INJECTABLE;INJECTION | 020327-002 | Oct 12, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | CHOLETEC | technetium tc-99m mebrofenin kit | INJECTABLE;INJECTION | 018963-001 | Jan 21, 1987 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | DIATRIZOATE MEGLUMINE | diatrizoate meglumine | INJECTABLE;INJECTION | 010040-017 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | E-Z-HD | barium sulfate | FOR SUSPENSION;ORAL | 208036-001 | Jan 11, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | RENOVIST | diatrizoate meglumine; diatrizoate sodium | INJECTABLE;INJECTION | 010040-020 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bracco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | ISOVUE-300 | iopamidol | INJECTABLE;INJECTION | 018735-002 | Dec 31, 1985 | 4,001,323 | ⤷ Try a Trial |
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | 6,803,046 | ⤷ Try a Trial |
Bracco | MULTIHANCE | gadobenate dimeglumine | INJECTABLE;INTRAVENOUS | 021357-003 | Nov 23, 2004 | 4,916,246 | ⤷ Try a Trial |
Bracco | CHOLOVUE | iodoxamate meglumine | INJECTABLE;INJECTION | 018076-001 | Approved Prior to Jan 1, 1982 | 3,654,272 | ⤷ Try a Trial |
Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | 5,686,060 | ⤷ Try a Trial |
Bracco | CHOLETEC | technetium tc-99m mebrofenin kit | INJECTABLE;INJECTION | 018963-001 | Jan 21, 1987 | 4,418,208 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bracco Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 3137089 | ⤷ Try a Trial |
Mexico | 2020012604 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2020229643 | ⤷ Try a Trial |
Israel | 288095 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2020229642 | ⤷ Try a Trial |
South Korea | 102556398 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bracco Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0579826 | SPC/GB02/042 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ERTAPENEM ((1R,5S,6S,8R,2'S,4'S)-2-(2-(3-CARBOXYPHENYLCARBAMOYL)PYRROLIDIN-4-YLTHIO)-6-(1-HYDROXYETHYL)-1-METHYLCARBAPENEM-3-CARBOXYLIC ACID), A PHARMACEUTICALLY ACCEPTABLE SALT OR IN VIVO HYDROLYSABLE ESTER THEREOF, ESPECIALLY AS THE MONOSODIUM SALT ERTA; REGISTERED: UK EU/1/02/216/001 20020422 |
1948158 | 1690020-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123 |
0480717 | SPC/GB98/025 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115 |
2203431 | CR 2015 00014 | Denmark | ⤷ Try a Trial | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119 |
1912999 | 1490062-5 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
1345920 | SPC/GB14/018 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MACITENTAN, WHICH IS N-(5-(4-BROMOPHENYL)-6-(2((5-BROMOPYRIMIDIN-2-YL)OXY)ETHOXY)PYRIMIDIN-4-YL)-N'-PROPYLSULFURIC DIAMIDE; REGISTERED: UK EU/1/13/893 20131220 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.